Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
499
Frequently Asked Questions
What is Market Cap of Amicus Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Amicus Therapeutics Inc market cap is $2.47B.
What is the 52-week high for Amicus Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Amicus Therapeutics Inc 52 week high is $12.65 as of September 06, 2025.
What is the 52-week low for Amicus Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Amicus Therapeutics Inc 52 week low is $5.51 as of September 06, 2025.
What is Amicus Therapeutics Inc stock price today?
Amicus Therapeutics Inc stock price today is $7.99.
What was Amicus Therapeutics Inc stock price yesterday?
Amicus Therapeutics Inc stock price yesterday was $8.02.
What is the PE ratio of Amicus Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Amicus Therapeutics Inc’s P/E ratio is -65.47.
What is the Price-to-Book ratio of Amicus Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Amicus Therapeutics Inc P/B ratio is 12.0931.
What is the 50-day moving average of Amicus Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Amicus Therapeutics Inc 50-day moving average is $6.65.
How many employess does Amicus Therapeutics Inc has?
